28697-17-8

Basic information

• Product Name: (R)-(+)-N-Boc-2-piperidinecarboxylic acid
• Synonyms: (R)-PIPERIDINE-1,2-DICARBOXYLIC ACID 1-TERT-BUTYL ESTER;(R)-(+)-N-BOC-2-PIPERIDINECARBOXYLIC ACID;(R)-(-)-N-BOC-PIPECOLIC ACID;(R)-N-BOC-PIPERIDINE-2-CARBOXYLIC ACID;(R)-N-TERT-BUTYLOXYCARBONYL-PIPERIDINE-2-CARBOXYLIC ACID;(R)-1-N-BOC-PIPECOLINIC ACID;(R)-1-N-BOC-PIPERIDINE-2-CARBOXYLIC ACID;(R)-(+)-1-(TERT-BUTOXYCARBONYL)-2-PIPERIDINECARBOXYLIC ACID
• CAS NO: 28697-17-8
• Molecular Formula: C₁₁H₁₉NO₄
• Molecular Weight: 229.27
• EINECS: 200-533-0
• Product Categories: Unusual amino acids;chiral;Amino Acids
• Mol File: 28697-17-8.mol
• Article Data: 25

Chemical Properties

• Melting Point: 116-119 °C(lit.)
• Boiling Point: 353.2±35.0 °C(Predicted)
• Appearance: White to brown/Crystalline Powder
• Density: 1.164±0.06 g/cm3(Predicted)
• Storage Temp.: Store at RT.
• Solubility: Soluble in 2ml dimethyl formamide 0.3gram.
• PKA: 4.03±0.20(Predicted)
• BRN: 480023
• CAS DataBase Reference: (R)-(+)-N-Boc-2-piperidinecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-(+)-N-Boc-2-piperidinecarboxylic acid(28697-17-8)
• EPA Substance Registry System: (R)-(+)-N-Boc-2-piperidinecarboxylic acid(28697-17-8)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 28697-17-8(Hazardous Substances Data)

Usage

Chemical Properties

white to light yellow crystal powder

Uses

Different sources of media describe the Uses of 28697-17-8 differently. You can refer to the following data:
1. It is also applied as catalytic agent and petrochemical additive. It is also an important organic intermediate used in agrochemicals, pharmaceuticals and dyestuff fields.
2. (R)-(+)-N-Boc-2-piperidinecarboxylic Acid is a useful intermediate for agrochemical, pharmaceuticals and dye industries.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1723-00-8 (R)-(+)-pipecolic acid 
• 4043-87-2 pipecolic Acid 
• 58632-95-4 2-(tert-Butoxycarbonyloxyimino)-2-phenylacetonitrile 
• 124-38-9 carbon dioxide 
• 75844-69-8 t-butyl piperidinecarboxylate 
• 138804-98-5 (2R,3R)-3-carboxy-2,3-dihydroxypropanoic acid (R)-2-carboxypiperidinium salt 
• 164456-75-1 1-(R)-tert-butyl 2-methyl piperidine-1,2-dicarboxylate 
• 18650-38-9 (R)-piperidine-2-carboxylic acid methyl ester hydrochloride 
• 1013212-42-4 tert-butyl 1-(R)-2-((S)-1,2-dihydroxylethyl)piperidine-1-carboxylate 
• 116696-85-6 (2S)-2-t-butoxycarbonylamino-3-phenylsulfonyl-1-(2-tetrahydropyranyloxy)propane 
• 170642-32-7 (S,S)-pseudoephedrine D-pipecolinamide 
• 596129-25-8 (+/-)-N-trifluoroacetyl pipecolic acid 
• 596129-26-9 (S)-1-(2,2,2-Trifluoro-acetyl)-piperidine-2-carboxylic acid (S)-3,4,4-trimethyl-2-oxo-tetrahydro-furan-3-yl ester 

Downstream Products

• 164456-75-1 1-(R)-tert-butyl 2-methyl piperidine-1,2-dicarboxylate 
• 848488-91-5 tert-butyl (R)-2-carbamoylpiperidine-1-carboxyl-ate 
• 688809-99-6 (R)-2-methoxymethylpiperidine hydrochloride 
• 134441-61-5 tert-butyl (2R)-2-(hydroxymethyl)piperidine-1-carboxylate 
• 482-21-3 (R)-(-)-cryptopleurine 
• 1472657-33-2 (R)-1-(3-bromo-2-methylphenylsulfonyl)-N-cycloheptylpiperidine-2-carboxamide 
• 1470025-91-2 (R)-2-((S)-1-phenylethyl)tetrahydroimidazo[1,5-a]pyridine-1,3(2H,5H)-dione 
• 1443215-04-0 desmethyltubulysin 

Relevant articles and documents

MEDICINE CONTAINING ANTIBODY DRUG CONJUGATE CONTAINING HEMIASTERLIN DERIVATIVE

PROBLEM TO BE SOLVED: To provide medicines containing an antibody drug conjugate containing a hemiasterlin derivative, in which specific cytotoxicity to target cells is given, while cytotoxicity to normal cells is suppressed. SOLUTION: Provided is a medicine represented by formula (2-1), and containing an antibody drug conjugate or a pharmaceutically acceptable salt thereof [where, mAb represents an antibody, q represents an integer from 1 to 8, b represents an integer from 1 to 5, Z is a group represented by formula (Z-1), formula (Z-2), formula (Z-3), formula (Za-1), formula (Za-2), formula (Za-3), formula (Za-4), or formula (Za-5)]. SELECTED DRAWING: None COPYRIGHT: (C)2020,JPOandINPIT

PIPERAZINYL PYRIMIDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF

Provided are piperazinyl pyrimidine derivatives of formula I having CCR4 antagonism, and the preparation method, pharmaceutical composition and use thereof in the preparation of a medicament. The medicament is useful for the treatment and preve

PIPERAZINYL PYRIMIDINE DERIVATIVES, PREPARATION METHOD AND USE THEREOF

Provided are piperazinyl pyrimidine derivatives of formula I having CCR4 antagonism, and the preparation method, pharmaceutical composition and use thereof in the preparation of a medicament. The medicament is useful for the treatment and preve